Cargando…

A phase I study of oral UFT/leucovorin and irinotecan, plus radiation for locally recurrent rectal cancer

Objectives: The aim of this phase I study is to identify the maximum tolerated dose (MTD) and recommended dose (RD) of CPT-11 in combination with UFT/LV and radiation in patients with locally recurrent rectal cancer. Methods: Patients with histologically proven rectal cancer with local recurrence we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikeda, Masataka, Sekimoto, Mitsugu, Fukunaga, Yosuke, Konishi, Koji, Fujiwara, Yushi, Mizushima, Tsunekazu, Takemasa, Ichiro, Yamamoto, Hirofumi, Doki, Yuichiro, Mori, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japan Society of Coloproctology 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768668/ https://www.ncbi.nlm.nih.gov/pubmed/31583301 http://dx.doi.org/10.23922/jarc.2016-009

Ejemplares similares

Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer
por: Yasui, Masayoshi, et al.
Publicado: (2006)

UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer
por: Petrioli, R, et al.
Publicado: (2004)

UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer
por: Alliot, C
Publicado: (2004)

Reply: UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer
por: Francini, G, et al.
Publicado: (2004)

Intraluminal migration of a spacer with small bowel obstruction: a case report of rare complication
por: Ogino, Takayuki, et al.
Publicado: (2012)

Feasibility of single-site laparoscopic colectomy with complete mesocolic excision for colon cancer: a prospective case–control comparison
por: Takemasa, Ichiro, et al.
Publicado: (2013)

Laparoscopic Bladder-Preserving Surgery for Enterovesical Fistula Complicated with Benign Gastrointestinal Disease
por: Mizushima, Tsunekazu, et al.
Publicado: (2012)

The efficiency of (18)F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer
por: Uemura, Mamoru, et al.
Publicado: (2021)

Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer
por: Sheikh, H Y, et al.
Publicado: (2008)

Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer
por: Delord, J-P, et al.
Publicado: (2007)

The effects of chemotherapy on primary small bowel cancer: A retrospective multicenter observational study in Japan
por: MIZUSHIMA, TSUNEKAZU, et al.
Publicado: (2013)

A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
por: Matsuda, Chu, et al.
Publicado: (2022)

Long-term outcome of adrenalectomy for metastasis resulting from colorectal cancer with other metastatic sites: A report of 3 cases
por: Uemura, Mamoru, et al.
Publicado: (2016)

Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn’s disease: a case report
por: Takeyama, Hiroshi, et al.
Publicado: (2013)

Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
por: Oh, S C, et al.
Publicado: (2005)

Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
por: Cellier, Patrice, et al.
Publicado: (2011)

Randomized phase II study of S-1 dosing schedule for resected colorectal cancer
por: Matsuda, Chu, et al.
Publicado: (2015)

Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study
por: Mizushima, Tsunekazu, et al.
Publicado: (2019)

Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery
por: Hata, Taishi, et al.
Publicado: (2019)

Single-site laparoscopic colectomy for rectosigmoid cancer with middle aortic syndrome: report of a case
por: Tamai, Koki, et al.
Publicado: (2015)

Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer
por: Osawa, Hideki, et al.
Publicado: (2016)

Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer
por: Hata, Tsuyoshi, et al.
Publicado: (2017)

Cell Cycle-Dependent Rho GTPase Activity Dynamically Regulates Cancer Cell Motility and Invasion In Vivo
por: Kagawa, Yoshinori, et al.
Publicado: (2013)

Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
por: Takada, Ryoji, et al.
Publicado: (2023)

Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer
por: Nishimura, Junichi, et al.
Publicado: (2020)

A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer
por: Hoff, P M, et al.
Publicado: (2008)

Administration Method of Adjuvant Tegafur‐Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study
por: Hata, Taishi, et al.
Publicado: (2021)

Rectal Cancer in a Patient with Bartter Syndrome: A Case Report
por: Fujino, Shiki, et al.
Publicado: (2017)

Survival outcomes of appendiceal mucinous neoplasms by histological type and stage: Analysis of 266 cases in a multicenter collaborative retrospective clinical study
por: Sueda, Toshinori, et al.
Publicado: (2019)

Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin
por: Kawakami, Takeshi, et al.
Publicado: (2023)

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
por: Chao, Y, et al.
Publicado: (2006)

Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial
por: Abe, Shinya, et al.
Publicado: (2023)

Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study
por: Hata, Taishi, et al.
Publicado: (2014)

Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis
por: Hamabe, Atsushi, et al.
Publicado: (2014)

Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer
por: Mokutani, Yukako, et al.
Publicado: (2016)

Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study
por: Sheikh, H Y, et al.
Publicado: (2007)

Nanoliposomal irinotecan in combination with leucovorin and 5-fluorouracil in advanced biliary tract cancers
por: Allo, Gabriel, et al.
Publicado: (2022)

Essential updates 2018/2019: Colorectal (benign): Recent updates (2018‐2019) in the surgical treatment of benign colorectal diseases
por: Ogino, Takayuki, et al.
Publicado: (2019)

A glucose carbonate apatite complex exhibits in vitro and in vivo anti-tumour effects
por: Yamamoto, Hirofumi, et al.
Publicado: (2015)

Development and evaluation of a Japanese prediction model for low anterior resection syndrome after rectal cancer surgery
por: Paku, Masakatsu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1s8td9s6j8bo7972i2mec3g7qo